Biomarkers of Alzheimer’s disease are ready for widespread use in clinical trials.
Biomarkers of Alzheimer’s disease are ready for widespread use in clinical trials.
Purinergic signaling, not mystical energy, may explain how acupuncture works.
Sequencing the DNA of individual neurons is a way to dissect the genes underlying major neurological and psychological disorders.
Is DNA damage an inevitable consequence of epigenetic reprogramming?
New technologies and mind-sets are required for information delivery in the age of genomics.
Visualizing neuronal activity in small brains over four dimensions
Page 1 of 1